Bio-Rad Laboratories, Inc. Class A
BIO
$1.83 (-0.55%)
1D
1W
3M
1Y
5Y
ALL
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 1 hours ago • BIO
Bio-Rad Reports Second-Quarter 2026 Financial Results
Business Wire • 12 days ago • BIO
Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
Seeking Alpha • about a month ago • BIO
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential
Reuters • about a month ago • BIO
BIO CEO says more consistency needed in FDA review process
The Motley Fool • about a month ago • BIO
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.